3-nitropyridine analogues as novel microtubule-targeting agents

Microtubule-targeting agents are an important class of anti-cancer drugs; their full potential is however not realized because of significant myelotoxicity and neurotoxicity. We here report 3-nitropyridine analogues as a novel group of microtubule-targeting agents with potent anti-cancer effects against a broad range of cancer types. We show that these 3-nitropyridines induce cell cycle arrest in the G2-M phase and inhibit tubulin polymerization by interacting with tubulin. Determination of the tubulin-4AZA2996 structure by X-ray crystallography demonstrated that this class of compounds binds to the colchicine-site of tubulin. Furthermore, the anti-cancer effect was demonstrated both in vitro and in vivo in a murine heterotopic xenograft model of colon cancer. When administered intravenously, 4AZA2891 effectively inhibited cancer growth. Whereas 3-nitropyridine compounds do not induce myelotoxicity at pharmacological doses, the neurotoxicity associated with microtubule-targeting agents is still present.

Authors

Institutions

Publication Details

Journal
PLoS ONE
Published
2024-11-07
DOI
https://doi.org/10.1371/journal.pone.0307153
Citations
2
Primary Topic
Microtubule and mitosis dynamics
Type
article
Field-Weighted Citation Impact
0.65

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

3-nitropyridine analogues as novel microtubule-targeting agents

Michel Olivier Steinmetz, Ling‐Jie Gao, Thierry Louat, Ben Sprangers et al.
2 citations
PLoS ONE
Microtubule and mitosis dynamics
0.65
article

3-nitropyridine analogues as novel microtubule-targeting agents

Michel Olivier Steinmetz, Ling‐Jie Gao, Thierry Louat, Ben Sprangers, Piet A. Herdewijn, Dorothée Bardiot, Steven De Jonghe, Andrea Enrico Prota, Jean Herman, Thomas Vercruysse, Leentje Persoons, Natacha Gaillard, Dirk Daelemans, Els Vanstreels, Mark Waer, Tinne Daems
article en
2 citations

Abstract

Microtubule-targeting agents are an important class of anti-cancer drugs; their full potential is however not realized because of significant myelotoxicity and neurotoxicity. We here report 3-nitropyridine analogues as a novel group of microtubule-targeting agents with potent anti-cancer effects against a broad range of cancer types. We show that these 3-nitropyridines induce cell cycle arrest in the G2-M phase and inhibit tubulin polymerization by interacting with tubulin. Determination of the tubulin-4AZA2996 structure by X-ray crystallography demonstrated that this class of compounds binds to the colchicine-site of tubulin. Furthermore, the anti-cancer effect was demonstrated both in vitro and in vivo in a murine heterotopic xenograft model of colon cancer. When administered intravenously, 4AZA2891 effectively inhibited cancer growth. Whereas 3-nitropyridine compounds do not induce myelotoxicity at pharmacological doses, the neurotoxicity associated with microtubule-targeting agents is still present.

PLoS ONEVol. 19(11)
University of Basel (CH), Rega Institute for Medical Research (BE), Paul Scherrer Institute (CH), KU Leuven (BE)
National Science Foundation, Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, Fonds Wetenschappelijk Onderzoek, KU Leuven, Paul Scherrer Institut, Vlaamse regering
Good health and well-being
Openalex Percentile: Top 31%
Microtubule and mitosis dynamics
0.65
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.